Drug Interaction Study With a Potential Alzheimer's Disease Compound

NCT00726726 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Interacting drugs - Cooperstown Cocktail (midazolam, warfarin, (+ vitamin K), caffeine, omeprazole and dextromethorphan)
DRUG: BMS-708163
DRUG: BMS-708163 + Cooperstown Cocktail

Sponsor

Bristol-Myers Squibb